Positron Corporation Announces Sale of Attrius PET and NeuSight PET-CT Scanners
Niagara Falls, NY, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron”…
KuCoin Announces Settlement with the DOJ, Ushering in a New Chapter of Compliance and Growth
VICTORIA, Seychelles, Jan. 28, 2025 /PRNewswire/ -- KuCoin, a global cryptocurrency exchange,…
Virtualware announces uplisting process to Euronext Growth
Paris, 28 January 2025 – Virtualware (EPA: MLVIR), a pioneer in 3D-driven enterprise…
BlackRock Canada Announces Final January Cash Distributions for the iShares Premium Money Market ETF
TORONTO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited…
Elevar Therapeutics Announces the Formation and Members of Scientific Advisory Board
January 27, 2025 12:39 ET | Source: Elevar Therapeutics Scientific Advisory Board…
MedX Holdings, Inc. (OTC: MEDH) Achieves PINK Current Status, Celebrates 20 Years of Lazydaze, Launches AI-Powered Vending, and Announces Bold Expansion Plans
Austin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- [Austin, Texas – [1/27/2025] – MedX…
Kia Announces 2024 Annual and Fourth Quarter Business Results
Kia posts 2024 Q4 global sales of 769,985 units, a 5% increase…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 24, 2025 16:05 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Kia Announces 2024 Annual and Fourth Quarter Business Results
Kia posts 2024 Q4 global sales of 769,985 units, a 5% increase…